🇺🇸 FDA
Patent

US 10058554

Sustained release small molecule drug formulation

granted A61KA61K31/341A61K31/519

Quick answer

US patent 10058554 (Sustained release small molecule drug formulation) held by Indivior UK Limited expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/341, A61K31/519, A61K47/10, A61K47/14